nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—kidney cancer—Hydrocortisone—systemic lupus erythematosus	0.134	0.261	CpDpCtD
Omeprazole—prostate cancer—Hydrocortisone—systemic lupus erythematosus	0.0969	0.189	CpDpCtD
Omeprazole—kidney cancer—Betamethasone—systemic lupus erythematosus	0.0818	0.159	CpDpCtD
Omeprazole—kidney cancer—Dexamethasone—systemic lupus erythematosus	0.0818	0.159	CpDpCtD
Omeprazole—prostate cancer—Betamethasone—systemic lupus erythematosus	0.0591	0.115	CpDpCtD
Omeprazole—prostate cancer—Dexamethasone—systemic lupus erythematosus	0.0591	0.115	CpDpCtD
Omeprazole—CYP2C18—Dapsone—systemic lupus erythematosus	0.0371	0.104	CbGbCtD
Omeprazole—ABCC3—Cyclosporine—systemic lupus erythematosus	0.0267	0.0748	CbGbCtD
Omeprazole—CYP11A1—Dexamethasone—systemic lupus erythematosus	0.0264	0.0742	CbGbCtD
Omeprazole—ABCG2—Leflunomide—systemic lupus erythematosus	0.0234	0.0657	CbGbCtD
Omeprazole—CYP1B1—Dexamethasone—systemic lupus erythematosus	0.0152	0.0426	CbGbCtD
Omeprazole—ABCG2—Mycophenolate mofetil—systemic lupus erythematosus	0.0145	0.0406	CbGbCtD
Omeprazole—ABCC3—Methotrexate—systemic lupus erythematosus	0.0141	0.0396	CbGbCtD
Omeprazole—ABCG2—Hydrocortisone—systemic lupus erythematosus	0.0116	0.0326	CbGbCtD
Omeprazole—ABCG2—Cyclosporine—systemic lupus erythematosus	0.011	0.0307	CbGbCtD
Omeprazole—CYP1A2—Leflunomide—systemic lupus erythematosus	0.00965	0.0271	CbGbCtD
Omeprazole—CYP2C8—Dapsone—systemic lupus erythematosus	0.00889	0.0249	CbGbCtD
Omeprazole—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0087	0.0244	CbGbCtD
Omeprazole—CYP2C8—Mycophenolate mofetil—systemic lupus erythematosus	0.0077	0.0216	CbGbCtD
Omeprazole—CYP2C19—Dapsone—systemic lupus erythematosus	0.00745	0.0209	CbGbCtD
Omeprazole—ABCG2—Dexamethasone—systemic lupus erythematosus	0.00722	0.0202	CbGbCtD
Omeprazole—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.00688	0.0193	CbGbCtD
Omeprazole—CYP1A1—Dexamethasone—systemic lupus erythematosus	0.00666	0.0187	CbGbCtD
Omeprazole—CYP2C9—Dapsone—systemic lupus erythematosus	0.0062	0.0174	CbGbCtD
Omeprazole—CYP2C8—Hydrocortisone—systemic lupus erythematosus	0.00618	0.0173	CbGbCtD
Omeprazole—CYP2C8—Cyclosporine—systemic lupus erythematosus	0.00584	0.0164	CbGbCtD
Omeprazole—ABCG2—Methotrexate—systemic lupus erythematosus	0.0058	0.0163	CbGbCtD
Omeprazole—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.00522	0.0146	CbGbCtD
Omeprazole—CYP2C19—Prednisone—systemic lupus erythematosus	0.00517	0.0145	CbGbCtD
Omeprazole—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.0049	0.0137	CbGbCtD
Omeprazole—ABCB1—Betamethasone—systemic lupus erythematosus	0.00447	0.0126	CbGbCtD
Omeprazole—CYP2C9—cardial valve—systemic lupus erythematosus	0.00443	0.163	CbGeAlD
Omeprazole—ABCB1—Prednisolone—systemic lupus erythematosus	0.00441	0.0124	CbGbCtD
Omeprazole—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00419	0.0117	CbGbCtD
Omeprazole—ABCB1—Prednisone—systemic lupus erythematosus	0.00417	0.0117	CbGbCtD
Omeprazole—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00412	0.0116	CbGbCtD
Omeprazole—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.00407	0.0114	CbGbCtD
Omeprazole—ABCB1—Cyclosporine—systemic lupus erythematosus	0.00395	0.0111	CbGbCtD
Omeprazole—CYP2C8—Dexamethasone—systemic lupus erythematosus	0.00385	0.0108	CbGbCtD
Omeprazole—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.00372	0.0104	CbGbCtD
Omeprazole—CYP3A4—Dapsone—systemic lupus erythematosus	0.0036	0.0101	CbGbCtD
Omeprazole—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.00323	0.00905	CbGbCtD
Omeprazole—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.00312	0.00877	CbGbCtD
Omeprazole—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.00312	0.00877	CbGbCtD
Omeprazole—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.00268	0.00752	CbGbCtD
Omeprazole—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00268	0.00752	CbGbCtD
Omeprazole—CYP3A4—Prednisolone—systemic lupus erythematosus	0.00265	0.00742	CbGbCtD
Omeprazole—ABCB1—Dexamethasone—systemic lupus erythematosus	0.0026	0.0073	CbGbCtD
Omeprazole—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00251	0.00703	CbGbCtD
Omeprazole—CYP3A4—Prednisone—systemic lupus erythematosus	0.0025	0.00701	CbGbCtD
Omeprazole—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.00245	0.00688	CbGbCtD
Omeprazole—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00237	0.00664	CbGbCtD
Omeprazole—ABCB1—Methotrexate—systemic lupus erythematosus	0.00209	0.00587	CbGbCtD
Omeprazole—ATP4A—blood plasma—systemic lupus erythematosus	0.00184	0.0676	CbGeAlD
Omeprazole—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00156	0.00437	CbGbCtD
Omeprazole—CYP2C19—urine—systemic lupus erythematosus	0.00123	0.0453	CbGeAlD
Omeprazole—CYP1A2—urine—systemic lupus erythematosus	0.00101	0.037	CbGeAlD
Omeprazole—ATP4A—connective tissue—systemic lupus erythematosus	0.00098	0.036	CbGeAlD
Omeprazole—CYP2C9—urine—systemic lupus erythematosus	0.000956	0.0351	CbGeAlD
Omeprazole—ABCC3—blood plasma—systemic lupus erythematosus	0.000937	0.0344	CbGeAlD
Omeprazole—ATP4A—kidney—systemic lupus erythematosus	0.000835	0.0306	CbGeAlD
Omeprazole—CYP3A4—urine—systemic lupus erythematosus	0.000729	0.0268	CbGeAlD
Omeprazole—CYP2D6—urine—systemic lupus erythematosus	0.000717	0.0263	CbGeAlD
Omeprazole—CYP2C19—blood plasma—systemic lupus erythematosus	0.000643	0.0236	CbGeAlD
Omeprazole—CYP11A1—connective tissue—systemic lupus erythematosus	0.000643	0.0236	CbGeAlD
Omeprazole—CYP2C8—blood plasma—systemic lupus erythematosus	0.000561	0.0206	CbGeAlD
Omeprazole—ATP4A—nervous system—systemic lupus erythematosus	0.000548	0.0201	CbGeAlD
Omeprazole—ATP4A—central nervous system—systemic lupus erythematosus	0.000527	0.0194	CbGeAlD
Omeprazole—CYP1A2—blood plasma—systemic lupus erythematosus	0.000525	0.0193	CbGeAlD
Omeprazole—CYP2C9—blood plasma—systemic lupus erythematosus	0.000499	0.0183	CbGeAlD
Omeprazole—ABCC3—kidney—systemic lupus erythematosus	0.000425	0.0156	CbGeAlD
Omeprazole—CYP1B1—connective tissue—systemic lupus erythematosus	0.00039	0.0143	CbGeAlD
Omeprazole—CYP3A4—blood plasma—systemic lupus erythematosus	0.00038	0.014	CbGeAlD
Omeprazole—CYP1B1—nephron tubule—systemic lupus erythematosus	0.000378	0.0139	CbGeAlD
Omeprazole—CYP2D6—blood plasma—systemic lupus erythematosus	0.000374	0.0137	CbGeAlD
Omeprazole—CYP11A1—nervous system—systemic lupus erythematosus	0.000359	0.0132	CbGeAlD
Omeprazole—CYP1B1—skin of body—systemic lupus erythematosus	0.000352	0.0129	CbGeAlD
Omeprazole—CYP11A1—central nervous system—systemic lupus erythematosus	0.000346	0.0127	CbGeAlD
Omeprazole—CYP1B1—kidney—systemic lupus erythematosus	0.000332	0.0122	CbGeAlD
Omeprazole—CYP1B1—cortex of kidney—systemic lupus erythematosus	0.000324	0.0119	CbGeAlD
Omeprazole—ABCC3—lung—systemic lupus erythematosus	0.000301	0.011	CbGeAlD
Omeprazole—CYP1B1—lymphoid tissue—systemic lupus erythematosus	0.000285	0.0105	CbGeAlD
Omeprazole—ABCG2—nephron tubule—systemic lupus erythematosus	0.000282	0.0103	CbGeAlD
Omeprazole—ABCC3—nervous system—systemic lupus erythematosus	0.000279	0.0102	CbGeAlD
Omeprazole—ABCB1—blood plasma—systemic lupus erythematosus	0.000269	0.00988	CbGeAlD
Omeprazole—CYP1B1—tendon—systemic lupus erythematosus	0.000268	0.00985	CbGeAlD
Omeprazole—ABCC3—central nervous system—systemic lupus erythematosus	0.000268	0.00985	CbGeAlD
Omeprazole—CYP2C8—kidney—systemic lupus erythematosus	0.000254	0.00934	CbGeAlD
Omeprazole—CYP1A1—skin of body—systemic lupus erythematosus	0.000249	0.00915	CbGeAlD
Omeprazole—CYP1B1—lung—systemic lupus erythematosus	0.000235	0.00864	CbGeAlD
Omeprazole—CYP1A1—kidney—systemic lupus erythematosus	0.000235	0.00862	CbGeAlD
Omeprazole—CYP1B1—nervous system—systemic lupus erythematosus	0.000218	0.008	CbGeAlD
Omeprazole—CYP1B1—central nervous system—systemic lupus erythematosus	0.00021	0.00771	CbGeAlD
Omeprazole—ABCG2—bone marrow—systemic lupus erythematosus	0.000194	0.0071	CbGeAlD
Omeprazole—ABCG2—lung—systemic lupus erythematosus	0.000175	0.00644	CbGeAlD
Omeprazole—CYP3A4—kidney—systemic lupus erythematosus	0.000172	0.00633	CbGeAlD
Omeprazole—CYP2D6—kidney—systemic lupus erythematosus	0.00017	0.00623	CbGeAlD
Omeprazole—CYP1A2—lung—systemic lupus erythematosus	0.000169	0.00619	CbGeAlD
Omeprazole—CYP1A1—lung—systemic lupus erythematosus	0.000166	0.00611	CbGeAlD
Omeprazole—CYP1A1—nervous system—systemic lupus erythematosus	0.000154	0.00566	CbGeAlD
Omeprazole—CYP1A1—central nervous system—systemic lupus erythematosus	0.000148	0.00545	CbGeAlD
Omeprazole—ABCB1—nephron tubule—systemic lupus erythematosus	0.000139	0.0051	CbGeAlD
Omeprazole—ABCB1—kidney—systemic lupus erythematosus	0.000122	0.00448	CbGeAlD
Omeprazole—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000119	0.00436	CbGeAlD
Omeprazole—CYP3A4—nervous system—systemic lupus erythematosus	0.000113	0.00415	CbGeAlD
Omeprazole—CYP2D6—nervous system—systemic lupus erythematosus	0.000111	0.00409	CbGeAlD
Omeprazole—CYP3A4—central nervous system—systemic lupus erythematosus	0.000109	0.004	CbGeAlD
Omeprazole—CYP2D6—central nervous system—systemic lupus erythematosus	0.000107	0.00393	CbGeAlD
Omeprazole—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000105	0.00385	CbGeAlD
Omeprazole—ABCB1—bone marrow—systemic lupus erythematosus	9.54e-05	0.0035	CbGeAlD
Omeprazole—ABCB1—lung—systemic lupus erythematosus	8.65e-05	0.00317	CbGeAlD
Omeprazole—ABCB1—nervous system—systemic lupus erythematosus	8.01e-05	0.00294	CbGeAlD
Omeprazole—ABCB1—central nervous system—systemic lupus erythematosus	7.71e-05	0.00283	CbGeAlD
Omeprazole—Pharyngitis—Methotrexate—systemic lupus erythematosus	3.93e-05	0.000397	CcSEcCtD
Omeprazole—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	3.93e-05	0.000396	CcSEcCtD
Omeprazole—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	3.93e-05	0.000396	CcSEcCtD
Omeprazole—Nausea—Leflunomide—systemic lupus erythematosus	3.92e-05	0.000395	CcSEcCtD
Omeprazole—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	3.91e-05	0.000395	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	3.91e-05	0.000394	CcSEcCtD
Omeprazole—Fatigue—Hydrocortisone—systemic lupus erythematosus	3.9e-05	0.000394	CcSEcCtD
Omeprazole—Vision blurred—Prednisone—systemic lupus erythematosus	3.89e-05	0.000392	CcSEcCtD
Omeprazole—Urethral disorder—Methotrexate—systemic lupus erythematosus	3.88e-05	0.000392	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	3.88e-05	0.000392	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	3.87e-05	0.000391	CcSEcCtD
Omeprazole—Pain—Hydrocortisone—systemic lupus erythematosus	3.87e-05	0.000391	CcSEcCtD
Omeprazole—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	3.87e-05	0.00039	CcSEcCtD
Omeprazole—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	3.87e-05	0.00039	CcSEcCtD
Omeprazole—Insomnia—Triamcinolone—systemic lupus erythematosus	3.85e-05	0.000389	CcSEcCtD
Omeprazole—Insomnia—Methylprednisolone—systemic lupus erythematosus	3.85e-05	0.000388	CcSEcCtD
Omeprazole—Infection—Dexamethasone—systemic lupus erythematosus	3.84e-05	0.000388	CcSEcCtD
Omeprazole—Infection—Betamethasone—systemic lupus erythematosus	3.84e-05	0.000388	CcSEcCtD
Omeprazole—Ill-defined disorder—Prednisone—systemic lupus erythematosus	3.83e-05	0.000386	CcSEcCtD
Omeprazole—Paraesthesia—Triamcinolone—systemic lupus erythematosus	3.83e-05	0.000386	CcSEcCtD
Omeprazole—Feeling abnormal—Prednisolone—systemic lupus erythematosus	3.82e-05	0.000385	CcSEcCtD
Omeprazole—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	3.82e-05	0.000385	CcSEcCtD
Omeprazole—Visual impairment—Methotrexate—systemic lupus erythematosus	3.82e-05	0.000385	CcSEcCtD
Omeprazole—Anaemia—Prednisone—systemic lupus erythematosus	3.81e-05	0.000385	CcSEcCtD
Omeprazole—Shock—Dexamethasone—systemic lupus erythematosus	3.8e-05	0.000384	CcSEcCtD
Omeprazole—Shock—Betamethasone—systemic lupus erythematosus	3.8e-05	0.000384	CcSEcCtD
Omeprazole—Dyspnoea—Triamcinolone—systemic lupus erythematosus	3.8e-05	0.000383	CcSEcCtD
Omeprazole—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	3.79e-05	0.000383	CcSEcCtD
Omeprazole—Nervous system disorder—Betamethasone—systemic lupus erythematosus	3.79e-05	0.000383	CcSEcCtD
Omeprazole—Agitation—Prednisone—systemic lupus erythematosus	3.79e-05	0.000383	CcSEcCtD
Omeprazole—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	3.79e-05	0.000382	CcSEcCtD
Omeprazole—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	3.79e-05	0.000382	CcSEcCtD
Omeprazole—Tachycardia—Dexamethasone—systemic lupus erythematosus	3.77e-05	0.000381	CcSEcCtD
Omeprazole—Tachycardia—Betamethasone—systemic lupus erythematosus	3.77e-05	0.000381	CcSEcCtD
Omeprazole—Angioedema—Prednisone—systemic lupus erythematosus	3.77e-05	0.00038	CcSEcCtD
Omeprazole—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	3.75e-05	0.000379	CcSEcCtD
Omeprazole—Dyspepsia—Triamcinolone—systemic lupus erythematosus	3.75e-05	0.000378	CcSEcCtD
Omeprazole—Erythema multiforme—Methotrexate—systemic lupus erythematosus	3.75e-05	0.000378	CcSEcCtD
Omeprazole—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	3.74e-05	0.000378	CcSEcCtD
Omeprazole—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	3.74e-05	0.000377	CcSEcCtD
Omeprazole—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	3.74e-05	0.000377	CcSEcCtD
Omeprazole—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	3.73e-05	0.000376	CcSEcCtD
Omeprazole—Malaise—Prednisone—systemic lupus erythematosus	3.72e-05	0.000375	CcSEcCtD
Omeprazole—Vertigo—Prednisone—systemic lupus erythematosus	3.71e-05	0.000374	CcSEcCtD
Omeprazole—Eye disorder—Methotrexate—systemic lupus erythematosus	3.7e-05	0.000374	CcSEcCtD
Omeprazole—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	3.7e-05	0.000373	CcSEcCtD
Omeprazole—Tinnitus—Methotrexate—systemic lupus erythematosus	3.69e-05	0.000373	CcSEcCtD
Omeprazole—Anorexia—Dexamethasone—systemic lupus erythematosus	3.69e-05	0.000372	CcSEcCtD
Omeprazole—Anorexia—Betamethasone—systemic lupus erythematosus	3.69e-05	0.000372	CcSEcCtD
Omeprazole—Urticaria—Prednisolone—systemic lupus erythematosus	3.68e-05	0.000371	CcSEcCtD
Omeprazole—Fatigue—Triamcinolone—systemic lupus erythematosus	3.67e-05	0.000371	CcSEcCtD
Omeprazole—Fatigue—Methylprednisolone—systemic lupus erythematosus	3.67e-05	0.00037	CcSEcCtD
Omeprazole—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	3.66e-05	0.000369	CcSEcCtD
Omeprazole—Asthenia—Cyclosporine—systemic lupus erythematosus	3.65e-05	0.000369	CcSEcCtD
Omeprazole—Pain—Triamcinolone—systemic lupus erythematosus	3.64e-05	0.000368	CcSEcCtD
Omeprazole—Pruritus—Cyclosporine—systemic lupus erythematosus	3.6e-05	0.000364	CcSEcCtD
Omeprazole—Urticaria—Hydrocortisone—systemic lupus erythematosus	3.6e-05	0.000363	CcSEcCtD
Omeprazole—Immune system disorder—Methotrexate—systemic lupus erythematosus	3.58e-05	0.000361	CcSEcCtD
Omeprazole—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	3.58e-05	0.000361	CcSEcCtD
Omeprazole—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	3.58e-05	0.000361	CcSEcCtD
Omeprazole—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	3.57e-05	0.00036	CcSEcCtD
Omeprazole—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	3.56e-05	0.00036	CcSEcCtD
Omeprazole—Hypertension—Prednisone—systemic lupus erythematosus	3.56e-05	0.000359	CcSEcCtD
Omeprazole—Chills—Methotrexate—systemic lupus erythematosus	3.55e-05	0.000359	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	3.52e-05	0.000355	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	3.52e-05	0.000355	CcSEcCtD
Omeprazole—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	3.51e-05	0.000355	CcSEcCtD
Omeprazole—Myalgia—Prednisone—systemic lupus erythematosus	3.51e-05	0.000354	CcSEcCtD
Omeprazole—Arthralgia—Prednisone—systemic lupus erythematosus	3.51e-05	0.000354	CcSEcCtD
Omeprazole—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	3.51e-05	0.000354	CcSEcCtD
Omeprazole—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	3.5e-05	0.000354	CcSEcCtD
Omeprazole—Anxiety—Prednisone—systemic lupus erythematosus	3.5e-05	0.000353	CcSEcCtD
Omeprazole—Alopecia—Methotrexate—systemic lupus erythematosus	3.5e-05	0.000353	CcSEcCtD
Omeprazole—Insomnia—Dexamethasone—systemic lupus erythematosus	3.5e-05	0.000353	CcSEcCtD
Omeprazole—Insomnia—Betamethasone—systemic lupus erythematosus	3.5e-05	0.000353	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	3.49e-05	0.000352	CcSEcCtD
Omeprazole—Diarrhoea—Cyclosporine—systemic lupus erythematosus	3.48e-05	0.000352	CcSEcCtD
Omeprazole—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	3.48e-05	0.000351	CcSEcCtD
Omeprazole—Paraesthesia—Betamethasone—systemic lupus erythematosus	3.47e-05	0.00035	CcSEcCtD
Omeprazole—Paraesthesia—Dexamethasone—systemic lupus erythematosus	3.47e-05	0.00035	CcSEcCtD
Omeprazole—Discomfort—Prednisone—systemic lupus erythematosus	3.47e-05	0.00035	CcSEcCtD
Omeprazole—Mental disorder—Methotrexate—systemic lupus erythematosus	3.47e-05	0.00035	CcSEcCtD
Omeprazole—Malnutrition—Methotrexate—systemic lupus erythematosus	3.45e-05	0.000348	CcSEcCtD
Omeprazole—Hypersensitivity—Prednisolone—systemic lupus erythematosus	3.41e-05	0.000344	CcSEcCtD
Omeprazole—Dyspepsia—Dexamethasone—systemic lupus erythematosus	3.4e-05	0.000343	CcSEcCtD
Omeprazole—Dyspepsia—Betamethasone—systemic lupus erythematosus	3.4e-05	0.000343	CcSEcCtD
Omeprazole—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	3.4e-05	0.000343	CcSEcCtD
Omeprazole—Urticaria—Triamcinolone—systemic lupus erythematosus	3.39e-05	0.000342	CcSEcCtD
Omeprazole—Urticaria—Methylprednisolone—systemic lupus erythematosus	3.38e-05	0.000341	CcSEcCtD
Omeprazole—Dysgeusia—Methotrexate—systemic lupus erythematosus	3.38e-05	0.000341	CcSEcCtD
Omeprazole—Body temperature increased—Triamcinolone—systemic lupus erythematosus	3.37e-05	0.00034	CcSEcCtD
Omeprazole—Dizziness—Cyclosporine—systemic lupus erythematosus	3.37e-05	0.00034	CcSEcCtD
Omeprazole—Anaphylactic shock—Prednisone—systemic lupus erythematosus	3.37e-05	0.00034	CcSEcCtD
Omeprazole—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	3.36e-05	0.000339	CcSEcCtD
Omeprazole—Decreased appetite—Dexamethasone—systemic lupus erythematosus	3.36e-05	0.000339	CcSEcCtD
Omeprazole—Decreased appetite—Betamethasone—systemic lupus erythematosus	3.36e-05	0.000339	CcSEcCtD
Omeprazole—Infection—Prednisone—systemic lupus erythematosus	3.35e-05	0.000338	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	3.34e-05	0.000337	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	3.34e-05	0.000337	CcSEcCtD
Omeprazole—Back pain—Methotrexate—systemic lupus erythematosus	3.34e-05	0.000337	CcSEcCtD
Omeprazole—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	3.33e-05	0.000336	CcSEcCtD
Omeprazole—Fatigue—Dexamethasone—systemic lupus erythematosus	3.33e-05	0.000336	CcSEcCtD
Omeprazole—Fatigue—Betamethasone—systemic lupus erythematosus	3.33e-05	0.000336	CcSEcCtD
Omeprazole—Shock—Prednisone—systemic lupus erythematosus	3.31e-05	0.000334	CcSEcCtD
Omeprazole—Pain—Betamethasone—systemic lupus erythematosus	3.31e-05	0.000334	CcSEcCtD
Omeprazole—Pain—Dexamethasone—systemic lupus erythematosus	3.31e-05	0.000334	CcSEcCtD
Omeprazole—Nervous system disorder—Prednisone—systemic lupus erythematosus	3.3e-05	0.000333	CcSEcCtD
Omeprazole—Tachycardia—Prednisone—systemic lupus erythematosus	3.29e-05	0.000332	CcSEcCtD
Omeprazole—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	3.28e-05	0.000331	CcSEcCtD
Omeprazole—Skin disorder—Prednisone—systemic lupus erythematosus	3.27e-05	0.00033	CcSEcCtD
Omeprazole—Hyperhidrosis—Prednisone—systemic lupus erythematosus	3.26e-05	0.000328	CcSEcCtD
Omeprazole—Vision blurred—Methotrexate—systemic lupus erythematosus	3.25e-05	0.000328	CcSEcCtD
Omeprazole—Asthenia—Hydrocortisone—systemic lupus erythematosus	3.25e-05	0.000328	CcSEcCtD
Omeprazole—Vomiting—Cyclosporine—systemic lupus erythematosus	3.24e-05	0.000327	CcSEcCtD
Omeprazole—Rash—Cyclosporine—systemic lupus erythematosus	3.21e-05	0.000324	CcSEcCtD
Omeprazole—Anorexia—Prednisone—systemic lupus erythematosus	3.21e-05	0.000324	CcSEcCtD
Omeprazole—Dermatitis—Cyclosporine—systemic lupus erythematosus	3.21e-05	0.000324	CcSEcCtD
Omeprazole—Pruritus—Hydrocortisone—systemic lupus erythematosus	3.2e-05	0.000323	CcSEcCtD
Omeprazole—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	3.2e-05	0.000323	CcSEcCtD
Omeprazole—Headache—Cyclosporine—systemic lupus erythematosus	3.19e-05	0.000322	CcSEcCtD
Omeprazole—Anaemia—Methotrexate—systemic lupus erythematosus	3.19e-05	0.000322	CcSEcCtD
Omeprazole—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	3.19e-05	0.000322	CcSEcCtD
Omeprazole—Feeling abnormal—Betamethasone—systemic lupus erythematosus	3.19e-05	0.000322	CcSEcCtD
Omeprazole—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	3.16e-05	0.000319	CcSEcCtD
Omeprazole—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	3.16e-05	0.000319	CcSEcCtD
Omeprazole—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	3.16e-05	0.000319	CcSEcCtD
Omeprazole—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	3.14e-05	0.000317	CcSEcCtD
Omeprazole—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	3.13e-05	0.000316	CcSEcCtD
Omeprazole—Rash—Mycophenolate mofetil—systemic lupus erythematosus	3.13e-05	0.000316	CcSEcCtD
Omeprazole—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	3.13e-05	0.000316	CcSEcCtD
Omeprazole—Headache—Mycophenolate mofetil—systemic lupus erythematosus	3.11e-05	0.000314	CcSEcCtD
Omeprazole—Malaise—Methotrexate—systemic lupus erythematosus	3.11e-05	0.000314	CcSEcCtD
Omeprazole—Vertigo—Methotrexate—systemic lupus erythematosus	3.1e-05	0.000313	CcSEcCtD
Omeprazole—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	3.1e-05	0.000312	CcSEcCtD
Omeprazole—Leukopenia—Methotrexate—systemic lupus erythematosus	3.09e-05	0.000311	CcSEcCtD
Omeprazole—Urticaria—Dexamethasone—systemic lupus erythematosus	3.07e-05	0.00031	CcSEcCtD
Omeprazole—Urticaria—Betamethasone—systemic lupus erythematosus	3.07e-05	0.00031	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	3.07e-05	0.00031	CcSEcCtD
Omeprazole—Dizziness—Prednisolone—systemic lupus erythematosus	3.06e-05	0.000309	CcSEcCtD
Omeprazole—Asthenia—Triamcinolone—systemic lupus erythematosus	3.06e-05	0.000309	CcSEcCtD
Omeprazole—Abdominal pain—Betamethasone—systemic lupus erythematosus	3.06e-05	0.000308	CcSEcCtD
Omeprazole—Body temperature increased—Betamethasone—systemic lupus erythematosus	3.06e-05	0.000308	CcSEcCtD
Omeprazole—Abdominal pain—Dexamethasone—systemic lupus erythematosus	3.06e-05	0.000308	CcSEcCtD
Omeprazole—Body temperature increased—Dexamethasone—systemic lupus erythematosus	3.06e-05	0.000308	CcSEcCtD
Omeprazole—Asthenia—Methylprednisolone—systemic lupus erythematosus	3.05e-05	0.000308	CcSEcCtD
Omeprazole—Insomnia—Prednisone—systemic lupus erythematosus	3.05e-05	0.000307	CcSEcCtD
Omeprazole—Nausea—Cyclosporine—systemic lupus erythematosus	3.02e-05	0.000305	CcSEcCtD
Omeprazole—Paraesthesia—Prednisone—systemic lupus erythematosus	3.02e-05	0.000305	CcSEcCtD
Omeprazole—Pruritus—Triamcinolone—systemic lupus erythematosus	3.01e-05	0.000304	CcSEcCtD
Omeprazole—Cough—Methotrexate—systemic lupus erythematosus	3.01e-05	0.000304	CcSEcCtD
Omeprazole—Pruritus—Methylprednisolone—systemic lupus erythematosus	3.01e-05	0.000304	CcSEcCtD
Omeprazole—Dizziness—Hydrocortisone—systemic lupus erythematosus	2.99e-05	0.000302	CcSEcCtD
Omeprazole—Dyspepsia—Prednisone—systemic lupus erythematosus	2.96e-05	0.000299	CcSEcCtD
Omeprazole—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	2.95e-05	0.000298	CcSEcCtD
Omeprazole—Chest pain—Methotrexate—systemic lupus erythematosus	2.94e-05	0.000296	CcSEcCtD
Omeprazole—Arthralgia—Methotrexate—systemic lupus erythematosus	2.94e-05	0.000296	CcSEcCtD
Omeprazole—Myalgia—Methotrexate—systemic lupus erythematosus	2.94e-05	0.000296	CcSEcCtD
Omeprazole—Decreased appetite—Prednisone—systemic lupus erythematosus	2.93e-05	0.000295	CcSEcCtD
Omeprazole—Rash—Prednisolone—systemic lupus erythematosus	2.92e-05	0.000295	CcSEcCtD
Omeprazole—Dermatitis—Prednisolone—systemic lupus erythematosus	2.92e-05	0.000295	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	2.92e-05	0.000294	CcSEcCtD
Omeprazole—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	2.91e-05	0.000294	CcSEcCtD
Omeprazole—Fatigue—Prednisone—systemic lupus erythematosus	2.9e-05	0.000293	CcSEcCtD
Omeprazole—Headache—Prednisolone—systemic lupus erythematosus	2.9e-05	0.000293	CcSEcCtD
Omeprazole—Discomfort—Methotrexate—systemic lupus erythematosus	2.9e-05	0.000293	CcSEcCtD
Omeprazole—Constipation—Prednisone—systemic lupus erythematosus	2.88e-05	0.000291	CcSEcCtD
Omeprazole—Vomiting—Hydrocortisone—systemic lupus erythematosus	2.88e-05	0.00029	CcSEcCtD
Omeprazole—Rash—Hydrocortisone—systemic lupus erythematosus	2.85e-05	0.000288	CcSEcCtD
Omeprazole—Dermatitis—Hydrocortisone—systemic lupus erythematosus	2.85e-05	0.000288	CcSEcCtD
Omeprazole—Confusional state—Methotrexate—systemic lupus erythematosus	2.84e-05	0.000286	CcSEcCtD
Omeprazole—Headache—Hydrocortisone—systemic lupus erythematosus	2.84e-05	0.000286	CcSEcCtD
Omeprazole—Dizziness—Triamcinolone—systemic lupus erythematosus	2.82e-05	0.000284	CcSEcCtD
Omeprazole—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	2.81e-05	0.000284	CcSEcCtD
Omeprazole—Dizziness—Methylprednisolone—systemic lupus erythematosus	2.81e-05	0.000284	CcSEcCtD
Omeprazole—Infection—Methotrexate—systemic lupus erythematosus	2.8e-05	0.000282	CcSEcCtD
Omeprazole—Feeling abnormal—Prednisone—systemic lupus erythematosus	2.77e-05	0.00028	CcSEcCtD
Omeprazole—Asthenia—Dexamethasone—systemic lupus erythematosus	2.77e-05	0.00028	CcSEcCtD
Omeprazole—Asthenia—Betamethasone—systemic lupus erythematosus	2.77e-05	0.00028	CcSEcCtD
Omeprazole—Nervous system disorder—Methotrexate—systemic lupus erythematosus	2.76e-05	0.000278	CcSEcCtD
Omeprazole—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	2.76e-05	0.000278	CcSEcCtD
Omeprazole—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	2.75e-05	0.000278	CcSEcCtD
Omeprazole—Nausea—Prednisolone—systemic lupus erythematosus	2.75e-05	0.000278	CcSEcCtD
Omeprazole—Pruritus—Dexamethasone—systemic lupus erythematosus	2.74e-05	0.000276	CcSEcCtD
Omeprazole—Pruritus—Betamethasone—systemic lupus erythematosus	2.74e-05	0.000276	CcSEcCtD
Omeprazole—Skin disorder—Methotrexate—systemic lupus erythematosus	2.73e-05	0.000276	CcSEcCtD
Omeprazole—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	2.72e-05	0.000275	CcSEcCtD
Omeprazole—Vomiting—Triamcinolone—systemic lupus erythematosus	2.71e-05	0.000273	CcSEcCtD
Omeprazole—Vomiting—Methylprednisolone—systemic lupus erythematosus	2.7e-05	0.000273	CcSEcCtD
Omeprazole—Nausea—Hydrocortisone—systemic lupus erythematosus	2.69e-05	0.000271	CcSEcCtD
Omeprazole—Rash—Triamcinolone—systemic lupus erythematosus	2.69e-05	0.000271	CcSEcCtD
Omeprazole—Dermatitis—Triamcinolone—systemic lupus erythematosus	2.68e-05	0.000271	CcSEcCtD
Omeprazole—Anorexia—Methotrexate—systemic lupus erythematosus	2.68e-05	0.000271	CcSEcCtD
Omeprazole—Rash—Methylprednisolone—systemic lupus erythematosus	2.68e-05	0.000271	CcSEcCtD
Omeprazole—Dermatitis—Methylprednisolone—systemic lupus erythematosus	2.68e-05	0.00027	CcSEcCtD
Omeprazole—Urticaria—Prednisone—systemic lupus erythematosus	2.68e-05	0.00027	CcSEcCtD
Omeprazole—Headache—Triamcinolone—systemic lupus erythematosus	2.67e-05	0.000269	CcSEcCtD
Omeprazole—Headache—Methylprednisolone—systemic lupus erythematosus	2.66e-05	0.000269	CcSEcCtD
Omeprazole—Abdominal pain—Prednisone—systemic lupus erythematosus	2.66e-05	0.000269	CcSEcCtD
Omeprazole—Body temperature increased—Prednisone—systemic lupus erythematosus	2.66e-05	0.000269	CcSEcCtD
Omeprazole—Diarrhoea—Betamethasone—systemic lupus erythematosus	2.65e-05	0.000267	CcSEcCtD
Omeprazole—Diarrhoea—Dexamethasone—systemic lupus erythematosus	2.65e-05	0.000267	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	2.56e-05	0.000259	CcSEcCtD
Omeprazole—Dizziness—Betamethasone—systemic lupus erythematosus	2.56e-05	0.000258	CcSEcCtD
Omeprazole—Dizziness—Dexamethasone—systemic lupus erythematosus	2.56e-05	0.000258	CcSEcCtD
Omeprazole—Insomnia—Methotrexate—systemic lupus erythematosus	2.55e-05	0.000257	CcSEcCtD
Omeprazole—Nausea—Triamcinolone—systemic lupus erythematosus	2.53e-05	0.000255	CcSEcCtD
Omeprazole—Paraesthesia—Methotrexate—systemic lupus erythematosus	2.53e-05	0.000255	CcSEcCtD
Omeprazole—Nausea—Methylprednisolone—systemic lupus erythematosus	2.53e-05	0.000255	CcSEcCtD
Omeprazole—Dyspnoea—Methotrexate—systemic lupus erythematosus	2.51e-05	0.000253	CcSEcCtD
Omeprazole—Somnolence—Methotrexate—systemic lupus erythematosus	2.5e-05	0.000252	CcSEcCtD
Omeprazole—Hypersensitivity—Prednisone—systemic lupus erythematosus	2.48e-05	0.00025	CcSEcCtD
Omeprazole—Dyspepsia—Methotrexate—systemic lupus erythematosus	2.48e-05	0.00025	CcSEcCtD
Omeprazole—Vomiting—Betamethasone—systemic lupus erythematosus	2.46e-05	0.000248	CcSEcCtD
Omeprazole—Vomiting—Dexamethasone—systemic lupus erythematosus	2.46e-05	0.000248	CcSEcCtD
Omeprazole—Decreased appetite—Methotrexate—systemic lupus erythematosus	2.45e-05	0.000247	CcSEcCtD
Omeprazole—Rash—Dexamethasone—systemic lupus erythematosus	2.44e-05	0.000246	CcSEcCtD
Omeprazole—Rash—Betamethasone—systemic lupus erythematosus	2.44e-05	0.000246	CcSEcCtD
Omeprazole—Dermatitis—Betamethasone—systemic lupus erythematosus	2.44e-05	0.000246	CcSEcCtD
Omeprazole—Dermatitis—Dexamethasone—systemic lupus erythematosus	2.44e-05	0.000246	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	2.43e-05	0.000245	CcSEcCtD
Omeprazole—Fatigue—Methotrexate—systemic lupus erythematosus	2.43e-05	0.000245	CcSEcCtD
Omeprazole—Headache—Dexamethasone—systemic lupus erythematosus	2.42e-05	0.000244	CcSEcCtD
Omeprazole—Headache—Betamethasone—systemic lupus erythematosus	2.42e-05	0.000244	CcSEcCtD
Omeprazole—Asthenia—Prednisone—systemic lupus erythematosus	2.42e-05	0.000244	CcSEcCtD
Omeprazole—Pain—Methotrexate—systemic lupus erythematosus	2.41e-05	0.000243	CcSEcCtD
Omeprazole—Pruritus—Prednisone—systemic lupus erythematosus	2.38e-05	0.00024	CcSEcCtD
Omeprazole—Feeling abnormal—Methotrexate—systemic lupus erythematosus	2.32e-05	0.000234	CcSEcCtD
Omeprazole—Diarrhoea—Prednisone—systemic lupus erythematosus	2.3e-05	0.000232	CcSEcCtD
Omeprazole—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	2.3e-05	0.000232	CcSEcCtD
Omeprazole—Nausea—Dexamethasone—systemic lupus erythematosus	2.3e-05	0.000232	CcSEcCtD
Omeprazole—Nausea—Betamethasone—systemic lupus erythematosus	2.3e-05	0.000232	CcSEcCtD
Omeprazole—Urticaria—Methotrexate—systemic lupus erythematosus	2.24e-05	0.000226	CcSEcCtD
Omeprazole—Dizziness—Prednisone—systemic lupus erythematosus	2.23e-05	0.000225	CcSEcCtD
Omeprazole—Abdominal pain—Methotrexate—systemic lupus erythematosus	2.22e-05	0.000224	CcSEcCtD
Omeprazole—Body temperature increased—Methotrexate—systemic lupus erythematosus	2.22e-05	0.000224	CcSEcCtD
Omeprazole—Vomiting—Prednisone—systemic lupus erythematosus	2.14e-05	0.000216	CcSEcCtD
Omeprazole—Rash—Prednisone—systemic lupus erythematosus	2.12e-05	0.000214	CcSEcCtD
Omeprazole—Dermatitis—Prednisone—systemic lupus erythematosus	2.12e-05	0.000214	CcSEcCtD
Omeprazole—Headache—Prednisone—systemic lupus erythematosus	2.11e-05	0.000213	CcSEcCtD
Omeprazole—Hypersensitivity—Methotrexate—systemic lupus erythematosus	2.07e-05	0.000209	CcSEcCtD
Omeprazole—Asthenia—Methotrexate—systemic lupus erythematosus	2.02e-05	0.000204	CcSEcCtD
Omeprazole—Nausea—Prednisone—systemic lupus erythematosus	2e-05	0.000202	CcSEcCtD
Omeprazole—Pruritus—Methotrexate—systemic lupus erythematosus	1.99e-05	0.000201	CcSEcCtD
Omeprazole—Diarrhoea—Methotrexate—systemic lupus erythematosus	1.93e-05	0.000194	CcSEcCtD
Omeprazole—Dizziness—Methotrexate—systemic lupus erythematosus	1.86e-05	0.000188	CcSEcCtD
Omeprazole—Vomiting—Methotrexate—systemic lupus erythematosus	1.79e-05	0.000181	CcSEcCtD
Omeprazole—Rash—Methotrexate—systemic lupus erythematosus	1.77e-05	0.000179	CcSEcCtD
Omeprazole—Dermatitis—Methotrexate—systemic lupus erythematosus	1.77e-05	0.000179	CcSEcCtD
Omeprazole—Headache—Methotrexate—systemic lupus erythematosus	1.76e-05	0.000178	CcSEcCtD
Omeprazole—Nausea—Methotrexate—systemic lupus erythematosus	1.67e-05	0.000169	CcSEcCtD
Omeprazole—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	1.27e-05	0.00299	CbGpPWpGaD
Omeprazole—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	1.27e-05	0.00298	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—CD40—systemic lupus erythematosus	1.26e-05	0.00296	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—CTLA4—systemic lupus erythematosus	1.24e-05	0.00292	CbGpPWpGaD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	1.23e-05	0.0029	CbGpPWpGaD
Omeprazole—CYP2C8—Biological oxidations—NAT2—systemic lupus erythematosus	1.2e-05	0.00283	CbGpPWpGaD
Omeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	1.2e-05	0.00282	CbGpPWpGaD
Omeprazole—CYP1B1—Biological oxidations—RXRA—systemic lupus erythematosus	1.19e-05	0.00281	CbGpPWpGaD
Omeprazole—CYP2C8—Metapathway biotransformation—NAT2—systemic lupus erythematosus	1.19e-05	0.00279	CbGpPWpGaD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	1.15e-05	0.00271	CbGpPWpGaD
Omeprazole—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	1.15e-05	0.00271	CbGpPWpGaD
Omeprazole—CYP2C19—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	1.13e-05	0.00266	CbGpPWpGaD
Omeprazole—CYP11A1—Corticotropin-releasing hormone—TGFB1—systemic lupus erythematosus	1.11e-05	0.00261	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	1.09e-05	0.00257	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—HLA-DQA1—systemic lupus erythematosus	1.09e-05	0.00257	CbGpPWpGaD
Omeprazole—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	1.09e-05	0.00256	CbGpPWpGaD
Omeprazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	1.08e-05	0.00255	CbGpPWpGaD
Omeprazole—ATP4B—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.08e-05	0.00255	CbGpPWpGaD
Omeprazole—CYP2C19—Biological oxidations—NAT2—systemic lupus erythematosus	1.07e-05	0.00252	CbGpPWpGaD
Omeprazole—CYP2C19—Metapathway biotransformation—NAT2—systemic lupus erythematosus	1.06e-05	0.00249	CbGpPWpGaD
Omeprazole—CYP1A1—PPARA activates gene expression—RXRA—systemic lupus erythematosus	1.05e-05	0.00247	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—systemic lupus erythematosus	1.05e-05	0.00247	CbGpPWpGaD
Omeprazole—CYP2D6—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	1.04e-05	0.00245	CbGpPWpGaD
Omeprazole—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	1.03e-05	0.00243	CbGpPWpGaD
Omeprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—systemic lupus erythematosus	1.03e-05	0.00242	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—HLA-DQB1—systemic lupus erythematosus	1.02e-05	0.0024	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	9.94e-06	0.00234	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	9.94e-06	0.00234	CbGpPWpGaD
Omeprazole—CYP2D6—Biological oxidations—NAT2—systemic lupus erythematosus	9.88e-06	0.00232	CbGpPWpGaD
Omeprazole—CYP1A1—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	9.82e-06	0.00231	CbGpPWpGaD
Omeprazole—CYP2C9—Biological oxidations—NAT2—systemic lupus erythematosus	9.79e-06	0.0023	CbGpPWpGaD
Omeprazole—CYP2D6—Metapathway biotransformation—NAT2—systemic lupus erythematosus	9.74e-06	0.00229	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	9.73e-06	0.00229	CbGpPWpGaD
Omeprazole—ABCG2—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	9.66e-06	0.00227	CbGpPWpGaD
Omeprazole—CYP2C9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	9.66e-06	0.00227	CbGpPWpGaD
Omeprazole—ATP4A—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	9.65e-06	0.00227	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—CD40LG—systemic lupus erythematosus	9.65e-06	0.00227	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—IL10—systemic lupus erythematosus	9.65e-06	0.00227	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—IL4—systemic lupus erythematosus	9.38e-06	0.00221	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	9.17e-06	0.00216	CbGpPWpGaD
Omeprazole—ABCG2—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	9.15e-06	0.00215	CbGpPWpGaD
Omeprazole—CYP2C8—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	9e-06	0.00212	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—FASLG—systemic lupus erythematosus	8.97e-06	0.00211	CbGpPWpGaD
Omeprazole—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	8.83e-06	0.00208	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	8.73e-06	0.00205	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	8.73e-06	0.00205	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—FAS—systemic lupus erythematosus	8.65e-06	0.00203	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—IL2RA—systemic lupus erythematosus	8.6e-06	0.00202	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—C3—systemic lupus erythematosus	8.52e-06	0.002	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—SLC15A4—systemic lupus erythematosus	8.43e-06	0.00198	CbGpPWpGaD
Omeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	8.41e-06	0.00198	CbGpPWpGaD
Omeprazole—CYP1A2—Biological oxidations—NAT2—systemic lupus erythematosus	8.37e-06	0.00197	CbGpPWpGaD
Omeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	8.36e-06	0.00197	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	8.27e-06	0.00194	CbGpPWpGaD
Omeprazole—CYP1A2—Metapathway biotransformation—NAT2—systemic lupus erythematosus	8.25e-06	0.00194	CbGpPWpGaD
Omeprazole—CYP2C19—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	8.03e-06	0.00189	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—HLA-DRB1—systemic lupus erythematosus	7.77e-06	0.00183	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	7.59e-06	0.00178	CbGpPWpGaD
Omeprazole—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—systemic lupus erythematosus	7.55e-06	0.00177	CbGpPWpGaD
Omeprazole—CYP1A1—Biological oxidations—RXRA—systemic lupus erythematosus	7.36e-06	0.00173	CbGpPWpGaD
Omeprazole—CYP2C9—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	7.32e-06	0.00172	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	7.19e-06	0.00169	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—CD80—systemic lupus erythematosus	7.18e-06	0.00169	CbGpPWpGaD
Omeprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—systemic lupus erythematosus	7.09e-06	0.00167	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	7.08e-06	0.00167	CbGpPWpGaD
Omeprazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	7.08e-06	0.00167	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	6.98e-06	0.00164	CbGpPWpGaD
Omeprazole—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	6.81e-06	0.0016	CbGpPWpGaD
Omeprazole—CYP2C8—Biological oxidations—RXRA—systemic lupus erythematosus	6.74e-06	0.00159	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—systemic lupus erythematosus	6.69e-06	0.00157	CbGpPWpGaD
Omeprazole—CYP1A1—PPARA activates gene expression—PPARG—systemic lupus erythematosus	6.64e-06	0.00156	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—systemic lupus erythematosus	6.54e-06	0.00154	CbGpPWpGaD
Omeprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—systemic lupus erythematosus	6.5e-06	0.00153	CbGpPWpGaD
Omeprazole—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	6.46e-06	0.00152	CbGpPWpGaD
Omeprazole—ABCC3—NRF2 pathway—TGFB1—systemic lupus erythematosus	6.45e-06	0.00152	CbGpPWpGaD
Omeprazole—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	6.37e-06	0.0015	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	6.34e-06	0.00149	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	6.34e-06	0.00149	CbGpPWpGaD
Omeprazole—CYP1A2—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	6.26e-06	0.00147	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	6.2e-06	0.00146	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUNB—systemic lupus erythematosus	6.17e-06	0.00145	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	6.05e-06	0.00142	CbGpPWpGaD
Omeprazole—CYP2C19—Biological oxidations—RXRA—systemic lupus erythematosus	6.02e-06	0.00142	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	5.85e-06	0.00138	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	5.75e-06	0.00135	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—NAT2—systemic lupus erythematosus	5.71e-06	0.00134	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—IFNG—systemic lupus erythematosus	5.67e-06	0.00133	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	5.56e-06	0.00131	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	5.56e-06	0.00131	CbGpPWpGaD
Omeprazole—CYP2D6—Biological oxidations—RXRA—systemic lupus erythematosus	5.54e-06	0.0013	CbGpPWpGaD
Omeprazole—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	5.49e-06	0.00129	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—systemic lupus erythematosus	5.4e-06	0.00127	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	5.27e-06	0.00124	CbGpPWpGaD
Omeprazole—ABCB1—HIF-1-alpha transcription factor network—EP300—systemic lupus erythematosus	5.22e-06	0.00123	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—IL2—systemic lupus erythematosus	5.04e-06	0.00119	CbGpPWpGaD
Omeprazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—systemic lupus erythematosus	4.95e-06	0.00116	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—NAT2—systemic lupus erythematosus	4.94e-06	0.00116	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	4.84e-06	0.00114	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—NAT2—systemic lupus erythematosus	4.81e-06	0.00113	CbGpPWpGaD
Omeprazole—CYP1A2—Biological oxidations—RXRA—systemic lupus erythematosus	4.69e-06	0.0011	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	4.59e-06	0.00108	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	4.54e-06	0.00107	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	4.52e-06	0.00106	CbGpPWpGaD
Omeprazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	4.52e-06	0.00106	CbGpPWpGaD
Omeprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—systemic lupus erythematosus	4.48e-06	0.00105	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—systemic lupus erythematosus	4.43e-06	0.00104	CbGpPWpGaD
Omeprazole—CYP1A1—PPARA activates gene expression—EP300—systemic lupus erythematosus	4.34e-06	0.00102	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—VEGFA—systemic lupus erythematosus	4.28e-06	0.00101	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—systemic lupus erythematosus	4.27e-06	0.001	CbGpPWpGaD
Omeprazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	4.25e-06	0.001	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	4.08e-06	0.00096	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	3.97e-06	0.000933	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—TGFB1—systemic lupus erythematosus	3.93e-06	0.000924	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.82e-06	0.000899	CbGpPWpGaD
Omeprazole—ABCB1—Allograft Rejection—TNF—systemic lupus erythematosus	3.67e-06	0.000863	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—NAT2—systemic lupus erythematosus	3.64e-06	0.000857	CbGpPWpGaD
Omeprazole—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	3.62e-06	0.000851	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.57e-06	0.00084	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	3.44e-06	0.000808	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—NAT2—systemic lupus erythematosus	3.32e-06	0.00078	CbGpPWpGaD
Omeprazole—ABCC3—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.27e-06	0.000768	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—RXRA—systemic lupus erythematosus	3.2e-06	0.000753	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	3.01e-06	0.000707	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.97e-06	0.000698	CbGpPWpGaD
Omeprazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	2.93e-06	0.000689	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.9e-06	0.000681	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.82e-06	0.000664	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—RXRA—systemic lupus erythematosus	2.77e-06	0.000652	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—RXRA—systemic lupus erythematosus	2.7e-06	0.000634	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—systemic lupus erythematosus	2.68e-06	0.000631	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.6e-06	0.000612	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.59e-06	0.000609	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—systemic lupus erythematosus	2.54e-06	0.000598	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	2.5e-06	0.000588	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—systemic lupus erythematosus	2.35e-06	0.000552	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.31e-06	0.000544	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.28e-06	0.000536	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	2.25e-06	0.00053	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—NAT2—systemic lupus erythematosus	2.24e-06	0.000528	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—systemic lupus erythematosus	2.23e-06	0.000525	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—RXRA—systemic lupus erythematosus	2.15e-06	0.000504	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—systemic lupus erythematosus	2.11e-06	0.000497	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.11e-06	0.000496	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—NAT2—systemic lupus erythematosus	2.06e-06	0.000484	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—RXRA—systemic lupus erythematosus	2.04e-06	0.00048	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PPARG—systemic lupus erythematosus	2.02e-06	0.000475	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—systemic lupus erythematosus	1.94e-06	0.000456	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.89e-06	0.000446	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—RXRA—systemic lupus erythematosus	1.86e-06	0.000437	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—NAT2—systemic lupus erythematosus	1.84e-06	0.000432	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—ALB—systemic lupus erythematosus	1.82e-06	0.000427	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—systemic lupus erythematosus	1.81e-06	0.000426	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.8e-06	0.000424	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—NAT2—systemic lupus erythematosus	1.79e-06	0.000421	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.78e-06	0.000419	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PPARG—systemic lupus erythematosus	1.75e-06	0.000411	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—NOS3—systemic lupus erythematosus	1.74e-06	0.000409	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PPARG—systemic lupus erythematosus	1.7e-06	0.0004	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—NAT2—systemic lupus erythematosus	1.69e-06	0.000397	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	1.67e-06	0.000394	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.64e-06	0.000384	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.6e-06	0.000377	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PTGS2—systemic lupus erythematosus	1.59e-06	0.000374	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—ALB—systemic lupus erythematosus	1.57e-06	0.00037	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—ALB—systemic lupus erythematosus	1.53e-06	0.00036	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—NOS3—systemic lupus erythematosus	1.5e-06	0.000354	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.47e-06	0.000346	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—NOS3—systemic lupus erythematosus	1.46e-06	0.000344	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.46e-06	0.000343	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	1.43e-06	0.000336	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.4e-06	0.00033	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PTGS2—systemic lupus erythematosus	1.38e-06	0.000324	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PTGS2—systemic lupus erythematosus	1.34e-06	0.000315	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.33e-06	0.000313	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—EP300—systemic lupus erythematosus	1.32e-06	0.000311	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.31e-06	0.000309	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PPARG—systemic lupus erythematosus	1.29e-06	0.000303	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.29e-06	0.000302	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—RXRA—systemic lupus erythematosus	1.26e-06	0.000296	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	1.22e-06	0.000286	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.2e-06	0.000281	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PPARG—systemic lupus erythematosus	1.17e-06	0.000276	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.17e-06	0.000274	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—ALB—systemic lupus erythematosus	1.16e-06	0.000273	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—RXRA—systemic lupus erythematosus	1.15e-06	0.000271	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.15e-06	0.00027	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—EP300—systemic lupus erythematosus	1.14e-06	0.000269	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.14e-06	0.000267	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—EP300—systemic lupus erythematosus	1.11e-06	0.000262	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—NOS3—systemic lupus erythematosus	1.11e-06	0.000261	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	1.1e-06	0.00026	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.07e-06	0.000252	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—ALB—systemic lupus erythematosus	1.06e-06	0.000248	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.05e-06	0.000246	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—RXRA—systemic lupus erythematosus	1.03e-06	0.000242	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.02e-06	0.00024	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTGS2—systemic lupus erythematosus	1.01e-06	0.000239	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—NOS3—systemic lupus erythematosus	1.01e-06	0.000237	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	1e-06	0.000236	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	9.55e-07	0.000225	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—RXRA—systemic lupus erythematosus	9.47e-07	0.000223	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	9.39e-07	0.000221	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTGS2—systemic lupus erythematosus	9.23e-07	0.000217	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	8.95e-07	0.00021	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	8.71e-07	0.000205	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—EP300—systemic lupus erythematosus	8.44e-07	0.000198	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	8.02e-07	0.000189	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PPARG—systemic lupus erythematosus	7.94e-07	0.000187	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—EP300—systemic lupus erythematosus	7.68e-07	0.000181	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.44e-07	0.000175	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PPARG—systemic lupus erythematosus	7.28e-07	0.000171	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ALB—systemic lupus erythematosus	7.14e-07	0.000168	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—NOS3—systemic lupus erythematosus	6.83e-07	0.000161	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ALB—systemic lupus erythematosus	6.55e-07	0.000154	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PPARG—systemic lupus erythematosus	6.5e-07	0.000153	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	6.34e-07	0.000149	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—NOS3—systemic lupus erythematosus	6.26e-07	0.000147	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTGS2—systemic lupus erythematosus	6.25e-07	0.000147	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	6.19e-07	0.000146	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	5.98e-07	0.000141	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	5.93e-07	0.000139	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ALB—systemic lupus erythematosus	5.84e-07	0.000137	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTGS2—systemic lupus erythematosus	5.73e-07	0.000135	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ALB—systemic lupus erythematosus	5.7e-07	0.000134	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—NOS3—systemic lupus erythematosus	5.59e-07	0.000131	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	5.46e-07	0.000128	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	5.38e-07	0.000126	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	5.33e-07	0.000125	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—EP300—systemic lupus erythematosus	5.2e-07	0.000122	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	5.14e-07	0.000121	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTGS2—systemic lupus erythematosus	5.11e-07	0.00012	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	5.1e-07	0.00012	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	5.06e-07	0.000119	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	4.99e-07	0.000117	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—EP300—systemic lupus erythematosus	4.76e-07	0.000112	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	4.7e-07	0.000111	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	4.66e-07	0.00011	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	4.55e-07	0.000107	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	4.36e-07	0.000102	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—EP300—systemic lupus erythematosus	4.25e-07	0.0001	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—EP300—systemic lupus erythematosus	4.15e-07	9.76e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	3.98e-07	9.37e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	3.91e-07	9.2e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	3.91e-07	9.19e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	3.88e-07	9.12e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	3.51e-07	8.26e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	3.36e-07	7.9e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	3.31e-07	7.79e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	3.07e-07	7.23e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	2.56e-07	6.01e-05	CbGpPWpGaD
